SHINICHI NUNODA
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position Professor (Fixed Term) |
|
Article types | Other |
Language | English |
Peer review | Peer reviewed |
Title | Registry Report on Heart Transplantation in Japan (June 2016). |
Journal | Formal name:Circulation journal : official journal of the Japanese Circulation Society Abbreviation:Circ J ISSN code:13469843/13474820 |
Domestic / Foregin | Domestic |
Publisher | The Japanese Circulation Society |
Volume, Issue, Page | 81(3),pp.298-303 |
Author and coauthor | Fukushima Norihide, Ono Minoru, Saiki Yoshikatsu, Sawa Yoshiki, Nunoda Shinichi, Isobe Mitsuaki |
Publication date | 2017/02 |
Summary | The Japanese Organ Transplant Act came into effect in October 1997 and the first heart transplant (Htx) procedure under this Act was performed in February 1999.1 The number of procedures increased steadily to around 10 per year, but then rose sharply to 44 in 2015 after a revision of the Act in July 2010.1–3 However, the number of Htx procedures remains low in international terms and the mean waiting period exceeded 1,150 days at the end of June 2016 because of a rapid increase in newly registered patients on the waiting list. A bridge to transplantation (BTT) using a left ventricular assist device (LVAD) plays a greater role than before in managing the listed patients, and the total number of CF-LVAD implantation patients enrolled in the Japanese registry for Mechanically Assisted Circulatory Support (J-MACS) increased to 656 at the end of June 2016. Because of the severe organ shortage, more marginal donor hearts are being transplanted than in other developed countries, but the outcomes of patients with these marginal hearts have not been well reported. This report is based on the latest statistics of Htx recipients and donors compiled by the Committee of Heart Transplantation Regitry of the Japanese Society for Heart Transplantation, which were correct as of June 30, 2016, to clarify the effects of recipient or donor factors on patient survival after Htx. |
DOI | 10.1253/circj.CJ-16-0976 |
PMID | 28070058 |